As an Amazon Associate, PauseAndFlourish earns from qualifying purchases.Product prices and availability are accurate as of the date reviewed.

PauseAndFlourishMenopause Wellness Reviews & Guidance

RCT

Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial

Study on active menopause symptoms and treatments.

Citation

Kikuno K, Asada R, Ishihara T, Morishige KI, Chikazawa K, Furui T, Isobe M. Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial.. Advances in therapy. 2025;42(12):6248-6260. doi:10.1007/s12325-025-03397-z

View Source